Priya Surabhi, Bamba Charu
Department of Anaesthesiology and Critical Care, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Anesth Essays Res. 2018 Apr-Jun;12(2):459-463. doi: 10.4103/aer.AER_27_18.
General anesthesia (GA) has been considered as the gold standard for breast cancer surgery. The problem of postoperative pain as well as the high incidence of nausea and vomiting has led to the search for a better modality for pain management with fewer side effects. In the last few years, paravertebral block (PVB) has gained immense popularity either in combination with GA or by itself for the anesthetic management of patients undergoing breast surgery.
Paravertebral block in breast surgery.
This study aims to evaluate the efficacy and duration of postoperative analgesia provided by ultrasound (USG)-guided PVB with bupivacaine and morphine versus bupivacaine and clonidine in patients undergoing modified radical mastectomy (MRM).
In the study, 70 patients who were scheduled for MRM were enrolled and randomly divided into Group M ( = 35) and Group C ( = 35). Both groups received USG-guided PVB at T2-T3 after administering GA. Group M received 2 mg/kg 0.5% bupivacaine with 0.05 mg/kg morphine and Group C received 2 mg/kg 0.5% bupivacaine with 1 μg/kg clonidine in the block. Postoperatively, pain intensity was recorded using the visual analog scale (VAS) (0-10 scale) at 1, 2, 6, 18, and 24 h duration when patients were resting and during a standardized movement. Modified Post Anaesthesia Discharge Scoring System was assessed at 1, 2, 6, 18 and 24 h after surgery.
In this study conducted on 70 patients, VAS scores (both at rest and on movement) were found comparable at postoperative 1, 2, 6, 18, and 24 h ( > 0.05). There was no statistical difference in comparing postanesthesia discharging scoring in both the groups. No incidence of postoperative nausea and vomiting was seen in any group.
Morphine and clonidine in PVB are equally effective, and there is no superiority of one agent over the other. Hence, both drugs may be used with equal efficacy as adjuvants to bupivacaine in PVB for providing postoperative analgesia.
全身麻醉(GA)一直被视为乳腺癌手术的金标准。术后疼痛问题以及恶心呕吐的高发生率促使人们寻找一种副作用更少的更好的疼痛管理方式。在过去几年中,椎旁阻滞(PVB)无论是与GA联合使用还是单独用于乳腺癌手术患者的麻醉管理,都广受欢迎。
乳腺癌手术中的椎旁阻滞。
本研究旨在评估超声(USG)引导下布比卡因与吗啡的PVB和布比卡因与可乐定的PVB在接受改良根治性乳房切除术(MRM)的患者中提供的术后镇痛效果和持续时间。
在本研究中,70例计划接受MRM的患者被纳入并随机分为M组(n = 35)和C组(n = 35)。两组在实施GA后均接受T2 - T3节段的USG引导下PVB。M组在阻滞中接受2mg/kg 0.5%布比卡因加0.05mg/kg吗啡,C组在阻滞中接受2mg/kg 0.5%布比卡因加1μg/kg可乐定。术后,在患者休息和进行标准化活动时,于1、2、6、18和24小时使用视觉模拟量表(VAS)(0 - 10分)记录疼痛强度。术后1、2、6、18和24小时评估改良麻醉后出院评分系统。
在对70例患者进行的本研究中,术后1、2、6、18和24小时的VAS评分(休息和活动时)相当(P > 0.05)。两组在比较麻醉后出院评分方面无统计学差异。两组均未出现术后恶心呕吐。
PVB中吗啡和可乐定同样有效,一种药物并不优于另一种。因此,在PVB中,两种药物作为布比卡因的佐剂用于提供术后镇痛时疗效相同。